Key takeaway
Of 1203 studies identified, 69 (5.74%) used AI-equipped wearables for anxiety or depression, about two-thirds for depression, mostly to diagnose and none to treat. Because this scoping review did not pool results, it shows what has been studied, not how well wearable AI works.
Study design
Evidence review
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Anxiety and depression are the most common mental disorders worldwide, and psychiatrists are scarce in many places, so AI built into wearables is being explored as a way to deliver mental health services. The authors set out to map the features of wearable AI used for anxiety and depression, to find where it is applied and what questions remain open.
Who and how
Scoping review. The authors searched 8 databases (MEDLINE, PsycINFO, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus and Google Scholar), then checked studies citing, and cited by, the included studies. Two reviewers selected studies and extracted data independently, and the data were summarized by narrative synthesis. The abstract does not report the search dates or any quality appraisal.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 169 of 1203 identified studies (5.74%) were included; about two-thirds addressed depression and the rest anxiety.
- 2Diagnosis was the most frequent application of wearable AI, and none of the studies used it for treatment.
- 3Most studies targeted people aged 18 to 65 years. Wrist-worn devices were the most common type, and the Actiwatch AW4 was the most used device.
- 4Physical activity data were most often used to build models, followed by sleep data and heart rate data. Random forest was the most common algorithm, followed by support vector machine, and Depresjon was the most used open data set.
Limits & uncertainty
- 1A scoping review describes what exists; it does not combine results, so it says nothing about how accurate or useful these systems are. The authors themselves call for later reviews to synthesize performance and effectiveness.
- 2The abstract gives no accuracy figures, so the conclusion that wearable AI is promising for prescreening is not backed by numbers here.
- 3The recommendation that technology companies should invest more is an opinion beyond what a descriptive map of studies can show.
- 4Heavy reliance on one open data set (Depresjon) and a few device types may limit how far findings generalize. This reading is based on the abstract only.
What to take from it
Research on wearable AI for mood disorders is active but concentrated on detection, not on helping people recover. A consumer wearable score is not a diagnosis of anxiety or depression. If you are struggling with mood or worry, talk with a clinician rather than relying on a device.
Reading your own data
The signals these studies used most, physical activity, sleep and heart rate, are the same things most watches and rings already record. Tracking them can show you your own patterns over weeks, but compare only against your own baseline on the same device, and treat changes as a prompt to reflect, not as a diagnosis.
How to read this evidence
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Anxiety and depression are the most common mental disorders worldwide. Owing to the lack of psychiatrists around the world, the incorporation of artificial intelligence (AI) into wearable devices (wearable AI) has been exploited to provide mental health services.
Objective
This review aimed to explore the features of wearable AI used for anxiety and depression to identify application areas and open research issues.
Methods
We searched 8 electronic databases (MEDLINE, PsycINFO, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar) and included studies that met the inclusion criteria. Then, we checked the studies that cited the included studies and screened studies that were cited by the included studies. The study selection and data extraction were carried out by 2 reviewers independently. The extracted data were aggregated and summarized using narrative synthesis.
Results
Of the 1203 studies identified, 69 (5.74%) were included in this review. Approximately, two-thirds of the studies used wearable AI for depression, whereas the remaining studies used it for anxiety. The most frequent application of wearable AI was in diagnosing anxiety and depression; however, none of the studies used it for treatment purposes. Most studies targeted individuals aged between 18 and 65 years. The most common wearable device used in the studies was Actiwatch AW4 (Cambridge Neurotechnology Ltd). Wrist-worn devices were the most common type of wearable device in the studies. The most commonly used category of data for model development was physical activity data, followed by sleep data and heart rate data. The most frequently used data set from open sources was Depresjon. The most commonly used algorithm was random forest, followed by support vector machine.
Conclusions
Wearable AI can offer great promise in providing mental health services related to anxiety and depression. Wearable AI can be used by individuals for the prescreening assessment of anxiety and depression. Further reviews are needed to statistically synthesize the studies' results related to the performance and effectiveness of wearable AI. Given its potential, technology companies should invest more in wearable AI for the treatment of anxiety and depression.
Sources & attribution
Wearable Artificial Intelligence for Anxiety and Depression: Scoping Review.
Abd-Alrazaq A, AlSaad R, Aziz S, Ahmed A, Denecke K, Househ M, Farooq F, Sheikh J.
Journal of medical Internet research · 2023-01-19
DOI: 10.2196/42672 ↗PubMed · 36656625 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

